High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT-Reference-Cited by-同舟云学术

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT

Published:2018-10 Issue: Volume:268 Page:11-17
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Zocca Paolo^ORCID,Kok Marlies M.,van der Heijden Liefke C.,van Houwelingen K. Gert,Hartmann Marc,de Man Frits H.A.F.,Stoel Martin G.,Louwerenburg J.(Hans) W.,Knottnerus Iris L.,Linssen Gerard C.M.,Doggen Carine J.M.,von Birgelen Clemens

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

3. Ticagrelor versus clopidogrel in patients with acute coronary syndromes;Wallentin;N. Engl. J. Med.,2009

4. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the platelet inhibition and patient outcomes (PLATO) trial;Becker;Eur. Heart J.,2011

5. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Clopidogrel vs. Ticagrelor in Dual Antiplatelet Therapy Regimens for High-Bleeding Risk Acute Coronary Syndrome Patients: A Comprehensive Meta-analysis of Adverse Outcomes;High Blood Pressure & Cardiovascular Prevention;2024-04-01

2. Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk;European Heart Journal - Cardiovascular Pharmacotherapy;2023-06-01

3. Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study;Research in Cardiovascular Medicine;2023

4. In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project;Thrombosis Research;2022-08

5. Oral Antiplatelet Agents in Percutaneous Coronary Intervention;Interventional Cardiology;2022-05-06